Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P, Dow edge higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.16
August 8, 2023 4:44 PM EDTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.16. Revenue for the quarter came in at $10.9 million, versus $0 reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More